Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | CTNNB1 | P35222 | 4/20 | 0.54 |
| ▸ | WNT3A | P56704 | 4/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 7/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.48 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25205712 | 1.00 | MAPK1 (0.55) | MAPK1CTNNB1WNT3AHCAR2FFAR1 | |
| SCHEMBL23794781 | 0.85 | GSK3B (0.58) | MAPK1CTNNB1WNT3AFFAR1ROCK2 | |
| SCHEMBL17871699 | 0.84 | MAPK1 (0.57) | MAPK1CTNNB1WNT3AROCK2ROCK1 | |
| SCHEMBL8666610 | 0.83 | NOS1 (0.57) | MAPK1CTNNB1WNT3AROCK2ROCK1 | |
| SCHEMBL25231993 | 0.80 | PDE3B (0.55) | MAPK1CTNNB1WNT3AHCAR2ROCK2 | |
| SCHEMBL30427608 | 0.80 | PDE3B (0.55) | MAPK1CTNNB1WNT3AHCAR2ROCK2 | |
| SCHEMBL6585051 | 0.79 | ROCK2 (0.58) | MAPK1CTNNB1WNT3AROCK2ROCK1 | |
| SCHEMBL795331 | 0.77 | ESR1 (0.67) | CTNNB1WNT3A | |
| SCHEMBL31280034 | 0.77 | ESR1 (0.67) | CTNNB1WNT3A | |
| SCHEMBL795332 | 0.77 | ESR1 (0.67) | CTNNB1WNT3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | MAPK1 2316/4885CTNNB1 4575/4885WNT3A 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.